Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 39.00
Bid: 38.70
Ask: 38.90
Change: 1.90 (5.12%)
Spread: 0.20 (0.517%)
Open: 36.80
High: 39.00
Low: 36.80
Prev. Close: 39.00
MARS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

28 Mar 2024 14:50

RNS Number : 7747I
Marston's PLC
28 March 2024
 

28 March 2024

 

Notification of interests of directors and persons discharging managerial responsibilities

 

Marston's PLC (the "Company") announces that on 28 March 2024 the Directors listed below were granted nil-cost options over ordinary shares in the Company under the Company's Long Term Incentive Plan ("Nil-Cost Options").

 

The Nil-Cost Options are in addition to certain nil-cost options granted to the Directors on 4 March 2024, which were granted over fewer shares than intended. The Nil-Cost Options which are the subject of this notification were therefore granted over such number of shares as was necessary to put the Directors in materially the same position as had the nil-cost options granted on 4 March 2024 been granted over the correct number of shares (and the number of shares over which the Nil-Cost Options have been granted has therefore also been calculated using the market price at the close of trading on the London Stock Exchange on 4 March 2024, being £0.2925 per ordinary share, save for the award granted to Hayleigh Lupino, where a notional share price of 33p was used to reflect the Remuneration Committee's decision to grant her an award over shares worth 125% of her base salary when the share price was 33p (which has decreased since that decision)).

 

Performance Metrics

 

Nil-Cost Options will vest to the extent performance conditions are satisfied as set out below:

 

Measure

Weighting

Threshold (25% vest)

Maximum (100% vest)

Underlying PBT in 20261

20%

£75m

£95m

Net cash flow2 (2024, 2025 and 2026 aggregate)

40%

£150m

£180m

Operating Margin in 2026

20%

16.3%

18.3%

Relative Total Shareholder Return (TSR) (measured over FY2023/24 to FY2025/2026)

20%

Median

Upper quartile

1. Underlying PBT: exclusive of income from associates.

2. Net cash inflow/(outflow) as per the Net Debt note to the financial statements.

3. Straight-line vesting applies between Threshold and Maximum.

 

To the extent the performance metrics are met, a Nil-Cost Option will be released following the end of a further two-year holding period.

 

Enquiries:

Bethan Raybould, General Counsel & Company Secretary, Marston's PLC, +44 (0) 1902 907250

 

 

Notification of Dealing Form

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Justin Platt

 

2.

Reason for the notification

a)

Position/status

Director and PDMR (Chief Executive Officer)

 

b)

Initial notification/ amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Marston's PLC

b)

LEI code

213800Q6RP3ZJ2CZR962

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification code

Ordinary Shares of 7.375 pence each

 

 

ISIN: GB00B1JQDM80

b)

Nature of the transaction

Grant of a nil-cost option under the Marston's PLC Long Term Incentive Plan.

 

c)

Price(s) and volumes(s)

 

Price

Volume

Nil-cost option: N/A

205,128

d)

Aggregated information

- Aggregate volume

 

- Price

 

205,128

 

N/A

 

e)

Date of the transaction

28-03-2024

f)

Place of the transaction

Outside a trading venue

 

 

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Hayleigh Lupino

 

2.

Reason for the notification

a)

Position/status

Director and PDMR (Chief Financial Officer)

 

b)

Initial notification/

amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Marston's PLC

b)

LEI code

213800Q6RP3ZJ2CZR962

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification code

Ordinary Shares of 7.375 pence each

 

 

ISIN: GB00B1JQDM80

b)

Nature of the transaction

Grant of a nil-cost option under the Marston's PLC Long Term Incentive Plan.

 

c)

Price(s) and volumes(s)

 

Price

Volume

Nil-cost option: N/A

205,128

d)

Aggregated information

- Aggregate volume

 

- Price

 

205,128

 

N/A

 

e)

Date of the transaction

28-03-2024

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEALDPALPLEFA
Date   Source Headline
27th Jan 20127:00 amRNSAGM and Interim Management Statement
23rd Jan 20127:01 amRNSAppointment of Non-executive Director
10th Jan 20129:25 amRNSBlocklisting Interim Review
3rd Jan 20122:41 pmRNSTotal Voting Rights
20th Dec 20118:38 amRNSAnnual Information Update
16th Dec 20113:07 pmRNSAnnual Financial Report
16th Dec 201110:26 amRNSDirector/PDMR Shareholding
12th Dec 201110:18 amRNSHolding(s) in Company
5th Dec 201111:56 amRNSHolding(s) in Company
1st Dec 201111:37 amRNSDirector/PDMR Shareholding
1st Dec 201111:30 amRNSTotal Voting Rights
30th Nov 20117:00 amRNSFinal Results
7th Nov 20119:14 amRNSDirectorate Change
1st Nov 201111:27 amRNSTotal Voting Rights
5th Oct 201111:01 amRNSHolding(s) in Company
5th Oct 20117:00 amRNSTrading Statement
4th Oct 20112:01 pmRNSDirector/PDMR Shareholding
3rd Oct 201112:42 pmRNSTotal Voting Rights
3rd Oct 201110:04 amRNSDirectorate Change
1st Sep 20118:55 amRNSTotal Voting Rights
1st Aug 20113:20 pmRNSTotal Voting Rights
11th Jul 201112:13 pmRNSBlocklisting Interim Review
30th Jun 201111:25 amRNSTotal Voting Rights
24th Jun 20114:21 pmRNSDirector/PDMR Shareholding
6th Jun 20117:00 amRNSFranchise Accreditation
31st May 20111:38 pmRNSTotal Voting Rights
19th May 20117:00 amRNSInterim Results
28th Apr 20119:22 amRNSTotal Voting Rights
31st Mar 20113:05 pmRNSTotal Voting Rights
25th Mar 20113:35 pmRNSDirector/PDMR Shareholding
16th Mar 20117:00 amRNSTrading Update
28th Feb 20112:19 pmRNSTotal Voting Rights
24th Feb 201111:32 amRNSDirector/PDMR Shareholding
17th Feb 20112:09 pmRNSDirector/PDMR Shareholding
31st Jan 20111:43 pmRNSTotal Voting Rights
28th Jan 20113:23 pmRNSResult of AGM
28th Jan 20117:00 amRNSAGM and Interim Management Statement
11th Jan 20115:31 pmRNSBlocklisting Interim Review
4th Jan 20117:00 amRNSTotal Voting Rights
20th Dec 20105:12 pmRNSAnnual Financial Report
20th Dec 201010:34 amRNSAnnual Information Update
2nd Dec 20107:00 amRNSPreliminary Results
30th Nov 20101:37 pmRNSTotal Voting Rights
29th Nov 20104:03 pmRNSHolding(s) in Company
26th Nov 20103:33 pmRNSNeil Goulden Appointed Chairman of Audit Committee
29th Oct 201011:51 amRNSTotal Voting Rights
6th Oct 20107:00 amRNSTrading Statement
30th Sep 20109:56 amRNSTotal Voting Rights
28th Sep 201011:17 amRNSBlocklisting Interim Review
1st Sep 201012:56 pmRNSNotice of Forthcoming Events

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.